Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-23

Clinical Trial Update: Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules [Phase 1]

View source ↗

Summary

Phase 1 study comparing the bioavailability of apixaban sprinkle formulation to standard capsule in healthy volunteers; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • apixaban sprinkle (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2020-01-23